Form 13-F position report

BETTER THERAPEUTICS INC COM (D

Reported by GEODE CAPITAL MANAGEMENT LLC

BTTX CUSIP 08773T104 Manager CIK 0001214717

Reported 0 shares, down 168,821 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 9 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 68000
2022-06-30 59000
2022-09-30 100000
2022-12-31 63000
2023-03-31 41575
2023-06-30 131461
2023-09-30 41233
2023-12-31 32920
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for BETTER THERAPEUTICS INC COM (D held by GEODE CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -168,821 (-100.0%) 0 $0 2024-05-13
Q4 2023 Added 168,821 +61,943 (58.0%) < 0.01% $32,920 2024-02-13
Q3 2023 Reduced 106,878 -14,846 (-12.2%) < 0.01% $41,233 2023-11-13
Q2 2023 Added 121,724 +64,615 (113.1%) < 0.01% $131,461 2023-08-11
Q1 2023 Unchanged 57,109 0 (0.0%) < 0.01% $41,575 2023-05-15
Q4 2022 Reduced 57,109 -135 (-0.2%) < 0.01% $63,000 2023-02-13
Q3 2022 Added 57,244 +19,300 (50.9%) < 0.01% $100,000 2022-11-14
Q2 2022 Added 37,944 +3,097 (8.9%) < 0.01% $59,000 2022-08-12
Q1 2022 New 34,847 +34,847 (0.0%) < 0.01% $68,000 2022-05-13

Who else reported the position

23 managers reported BETTER THERAPEUTICS INC COM (D for Q1 2024.

Managers reporting BETTER THERAPEUTICS INC COM (D in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Capital Investment Advisory Services LLC Unchanged 71,000 0 < 0.01% $994 3 qtrs
XTX Topco Ltd Added 32,670 +18,198 < 0.01% $457 2 qtrs
Aspire Private Capital LLC Unchanged 200 0 < 0.01% $3 8 qtrs
GROUP ONE TRADING L P Reduced 0 -10,351 0 $0 6 qtrs
AMERIPRISE FINANCIAL INC Reduced 0 -15,000 0 $0 7 qtrs
PSI Advisors LLC Reduced 0 -65 0 $0 10 qtrs
MMCAP International Inc SPC Reduced 0 -356,270 0 $0 3 qtrs
STATE STREET CORPORATION Reduced 0 -58,600 0 $0 10 qtrs
HRT FINANCIAL LP Reduced 0 -25,312 0 $0 2 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 0 -38,057 0 $0 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 13, 2024
Filing type
13F-HR
Position type
COMMON STOCK

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.